French drugmaker Sanofi-Synthelabo’s (SASY.PA: Quote, Profile, Research) hostile bid for larger rival Aventis (AVEP.PA: Quote, Profile, Research) opened on Tuesday amid talk other drug companies could step in to buy Aventis in a friendly deal.
French drugmaker Sanofi-Synthelabo’s (SASY.PA: Quote, Profile, Research) hostile bid for larger rival Aventis (AVEP.PA: Quote, Profile, Research) opened on Tuesday amid talk other drug companies could step in to buy Aventis in a friendly deal.